InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-01 · accession 0000014272-25-000136 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-05 2025-08-01 BMY Gallman Cari EVP, GC F - Tax $44.23 -543 8,840 -6% -$24.0K
D 2025-08-05 2025-08-01 BMY Gallman Cari EVP, GC M - OptEx $0.00 +1,061 9,383 +13% $0
D 2025-08-05 2025-08-01 BMY Gallman Cari EVP, GC M - OptEx $0.00 -1,061 1,061 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2025-08-01 F D 543 $44.23 8,840 D — — (F2) Shares withheld for payment of taxes upon vesting of award.
2 Common Common Stock, $0.10 par value 2025-08-01 M A 1,061 $0.00 9,383 D — — (F1) These restricted stock units vest in three equal installments beginning on August 1, 2024.
3 Derivative Restricted Stock Units 2025-08-01 M D 1,061 $0.00 1,061 D — · — to 2026-08-01 1,061 Common Stock, $0.10 par value (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) These restricted stock units vest in three equal installments beginning on August 1, 2024.